Virometix raised €7.0M in a Series B round in Jul 2020. The company is based in Schlieren, Switzerland. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
No investors disclosed for this round.
